HUMAN CD8 RESPONDER CELLS CAN BE DIRECTLY ACTIVATED TO PROLIFERATE AND TO PRODUCE IL-2 FOLLOWING STIMULATION BY ALLOGENEIC, BUT NOT BY XENOGENEIC, PORCINE BLOOD MONONUCLEAR-CELLS
N. Kawagishi et al., HUMAN CD8 RESPONDER CELLS CAN BE DIRECTLY ACTIVATED TO PROLIFERATE AND TO PRODUCE IL-2 FOLLOWING STIMULATION BY ALLOGENEIC, BUT NOT BY XENOGENEIC, PORCINE BLOOD MONONUCLEAR-CELLS, Xenotransplantation, 4(2), 1997, pp. 95-102
In order to determine the precise nature of human T lymphocytes reacti
vity against porcine stimulator cells, purified CD4+ and CD8+ human pe
ripheral T lymphocytes have been tested for their responsiveness again
st porcine stimulator cells. In a xenogeneic mixed lymphocyte reaction
(MLR), CD4+ T cells were capable of proliferating as a result of the
recognition of porcine peripheral blood lymphocytes (PBL), whereas CD8
+ T cells were unresponsive. A proliferative response of CD8+ T cells
could be restored by treatment with human IL-2, but not by IL-1 alpha,
IL-1 beta, or IL-6. Production of IL-2 was not detected in the xenost
imulated CD8+ responder cells, nor could IL-2 production be restored b
y the addition of IL-1 alpha, IL-1 beta, or IL-6. The presence of huma
n CD4+ responder cells was crucial both for a xenoproliferative respon
se and for IL-2 synthesis. However, when the expression of the IL-2 re
ceptor (CD25) on the CD8+ T cells was analyzed, no difference was dete
cted between xenostimulated and allostimulated CD8+ T cells, When the
development of cytotoxic T cells in xenogeneic and allogeneic MLRs was
compared, the cytotoxic activity exhibited by purified CD8+ T cells i
n xenogeneic MLR was significantly lower than that in the allogeneic c
ombination. In the xenogeneic combination, exogenous IL-2 reconstitute
d the cytotoxicity by purified CD8+ T cells; however, IL-1 alpha, IL-1
beta, or IL-6 did not, Our results show that purified human CD4+ T ce
lls respond directly against pig PBMCs, whereas purified CD8+ T cells
do not. Furthermore, responsiveness in CD8+ T cells is completely rest
ored by the addition of human IL-2.